HomeInsights52 Week Low Stocks

Jagsonpal Pharmaceuticals Ltd 52 Week Low

Jagsonpal Pharmaceuticals Ltd 52 Week Low

stocks purchased

₹ 1.6 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

25.6 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 23, 2024

Image

Jagsonpal Pharmaceuticals Ltd

NSE: JAGSNPHARM

YEARLOW

₹ 270.05

Last updated on: Nov 22, 2024

Key Highlights

  • The 52 Week Low of Jagsonpal Pharmaceuticals Ltd is ₹ 270.05 as of 22 Nov 24 .

Company Fundamentals for Jagsonpal Pharmaceuticals Ltd

No data available

Market Price of Jagsonpal Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Jagsonpal Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 2024640.2
21 Nov 2024591.65
19 Nov 2024578.1
18 Nov 2024591.7
14 Nov 2024533.2
13 Nov 2024531.9
12 Nov 2024561.25
11 Nov 2024570.15
08 Nov 2024590.8
07 Nov 2024598.75

Asset Value vs Market Value of Jagsonpal Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Jagsonpal Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Jagsonpal Pharmaceuticals Ltd

No data available

* All values are in crore

Jagsonpal Pharmaceuticals Ltd News Hub

News

Jagsonpal Pharmaceuticals to table results

Jagsonpal Pharmaceuticals will hold a meeting of the Board of Directors of the Company on ...

Read more

17 Oct 202412:13

News

Jagsonpal Pharmaceuticals AGM scheduled

Jagsonpal Pharmaceuticals announced that the 45th Annual General Meeting (AGM) of the comp...

Read more

13 Aug 202414:22

News

Jagsonpal Pharmaceuticals declare Quarterly Result

Jagsonpal Pharmaceuticals will hold a meeting of the Board of Directors of the Company on ...

Read more

01 Aug 202411:06

News

Jagsonpal Pharmaceuticals completes acquisition of India and Bhutan biz of Yash Pharma

Jagsonpal Pharmaceuticals completed the acquisition of India & Bhutan business of Yash Pha...

Read more

31 May 202414:15

News

Board of Jagsonpal Pharmaceuticals recommends final dividend

Jagsonpal Pharmaceuticals announced that the Board of Directors of the Company at its meet...

Read more

21 May 202409:56

News

Jagsonpal Pharmaceuticals Ltd leads losers in 'B' group

Pakka Ltd, IFGL Refractories Ltd, Mangalore Chemicals & Fertilizers Ltd and SBC Exports Lt...

Read more

05 Feb 202414:45

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week Low of Jagsonpal Pharmaceuticals Ltd

Why is it important to track the 52-week low of Jagsonpal Pharmaceuticals Ltd stocks?

Investors should monitor the 52-week low of Jagsonpal Pharmaceuticals Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time. Frequent monitoring will help traders identify trends and make timely decisions.

What factors can lead to Jagsonpal Pharmaceuticals Ltd stocks hitting a 52-week low?

Factors leading to Jagsonpal Pharmaceuticals Ltd stocks hitting a 52-week low may include poor fiscal results, negative industry trends, macroeconomic issues, or management changes. Other factors such as market volatility and broader economic downturns can also contribute to a 52-week low.

Should investors buy Jagsonpal Pharmaceuticals Ltd stocks when they hit a 52-week low?

Buying Jagsonpal Pharmaceuticals Ltd stocks at a 52-week low can offer a potential bargain, however, it is crucial to evaluate the reasons behind the stock price drop and ensure there is no underlying fundamental issue. Investors should consider the company's long-term prospects before making a buying decision.

How often should investors monitor the 52-week low of Jagsonpal Pharmaceuticals Ltd stocks?

Investors should monitor the 52-week low of Jagsonpal Pharmaceuticals Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time, which will help them identify trends and make timely decisions.

How can an investor assess the risk of buying Jagsonpal Pharmaceuticals Ltd stock at their 52-week low?

An investor can analyze the reasons for the Jagsonpal Pharmaceuticals Ltd stock price drop, evaluate the company’s fundamentals, and consider market conditions. Investors should also review the stock’s historical performance and any potential recovery indicators.

Should investors consider the overall market trend when evaluating Jagsonpal Pharmaceuticals Ltd stocks at their 52-week low?

Certainly, considering the overall market trend when evaluating Jagsonpal Pharmaceuticals Ltd stocks at their 52-week low is significant as it provides context for the stock’s performance and potential future movements. A declining market trend may influence Jagsonpal Pharmaceuticals Ltd stock performance, impacting the timing and potential of the investment.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*